期刊文献+

静脉滴注乌拉地尔对急性心力衰竭患者血浆脑钠肽水平的影响及意义 被引量:6

Effect of intravenous administration of urapidil on plasma brain natriuretic peptide level of patients with acute heart failure
下载PDF
导出
摘要 目的探讨静脉滴注乌拉地尔对急性心力衰竭患者血浆脑钠肽(BNP)的影响及临床疗效。方法将50例因各种原因引起的急性心力衰竭患者,心功能按纽约心脏协会(NYHA)分为Ⅲ~Ⅳ级,随机分为乌拉地尔治疗组24例,对照组26例,两组均给予常规治疗,包括利尿剂、口服血管紧张素转换酶抑制剂、强心剂,治疗组在此治疗基础上静脉持续泵入乌拉地尔50~400μg/min,硝酸甘油对照组在常规治疗基础上持续静脉滴入硝酸甘油15~50μg/min,疗程为3~10天,通过观察两组患者血浆脑钠肽浓度变化来判断心功能改善情况。结果治疗组与对照组比较,BNP降低显著,(216.2±115.3)ng/L vs(446.5±104.4)ng/L(P〈0.01),左室射血分数增加明显,(42±8)%vs(36±6)%(P〈0.01),收缩压降低显著,(100.0±12,8)mmHg vs(111.0±14.3)mmHg(P〈0.01),心率降低,(95.0±10)次/min vs(88±12)次/min(P〈0.05)。未见严重不良反应。结论乌拉地尔能明显降低急性心力衰竭患者血浆BNP浓度,改善心功能,治疗急性心力衰竭安全有效。 Objective To explore the difference of brain natriuretie peptide(BNP) concentration and clinical effects in patients with acute heart failure who received urapidil treatment intravenously. Methods Fifty eases for various reasons in acute heart failure caused by cardiac function NYHA Ⅲ - Ⅳ of the patients were randomly divided into urapidil treatment group(24 eases), control group(26 eases), the two groups were given conventional treatment, including diuretics, oral angiotensin-eonverting enzyme inhibitors, tonic, in treatment group on the basis of this treatment intravenously pumped into urapidil 50-400 μg/min, nitroglycerin conventional treatment in control group on the basis of continuous intravenous infusion of nitroglycerin 15-50 μg/min, the treatment lasted for three to ten days, plasma BNP concentration of two groups was observed to judge cardiac function. Results Treatment group showed significant decrease in BNP compared with control group (216.2± 115.3) ng/L vs (446.5 ±104.4) ng/L( P 〈0.01), left ventrieular ejection fraction (42 ± 8)% vs (36 ± 6) % ( P 〈 0.01), systolic blood pressure showed more decrease, (100.0±12.8) mm Hg than (111.0±14.3) mm Hg( P 〈0.01) ,heart rate reduced significantly (95±10) beats/min vs (88 ± 12) beats/min( P 〈 0.05). No serious adverse reactions occurred. Conclusion Urapidil can significantly reduce plasma BNP level of acute heart failure patients,improve cardiac function as a safe and effective treatment for acute heart failure.
出处 《临床荟萃》 CAS 北大核心 2008年第4期252-254,共3页 Clinical Focus
关键词 心力衰竭 充血性 药物疗法 肾上腺素能Α拮抗剂 heart failure, congestive drug therapy adrenergie alpha-antagonists
  • 相关文献

参考文献5

二级参考文献14

  • 1VENUGOPAL J.Cardiac natriuretic peptides-hope or hype?[J].J Clin Pharm Ther,2001,26(1):15-31.
  • 2MUKOYAMA M,NAKAO K,HOSODA K,et al.Brain natriuretic peptide as a novel cardiac hormone in humans:Evidence for an exquisite dual natriuretic peptide system,atrial natriuretic peptide and brain natriuretic peptide[J].J Clin Invest,1991,87(4):1402-1412.
  • 3MULDER P, RICHARD V,DERUMEAUX G, et al.Role of endogenous endothelin in chronic heart failure:effect of long-term treatment with an endothelin antagonist on survival,hemodynamics,and cardiac remodeling[J].Circulation,1997,96(6):1976-1982.
  • 4SAKAI S,MIYAUCHI T,KOBAYASHI M,et al.Inhibition of myocardial endothelin pathway improves long-term survival in heart failure[J].Nature,1996,384(6607):353-355.
  • 5BEST P J,LERMAN A.Endothelin in cardiovascular disease:from atherosclerosis to heart failur[J]. J Cardiovasc Pharmacol,2000,35(4 suppl 2):s61-s63.
  • 6raquet H,Komaida M,Grenier O.Plasma calcitonin gene related peptide decrease in chronic congestive heart failure.Eur Heart J.1992,13:1473.
  • 7胡正清.降钙素基因相关肽与心力衰竭[J].中国危重病急救医学,1997,9(6):378-380. 被引量:7
  • 8张军,刘洪,林连成.静脉滴注尼卡地平和硝普钠治疗高血压急症的比较[J].中国新药与临床杂志,1998,17(3):138-140. 被引量:4
  • 9陈良海,罗兴林,李刚.降钙素基因相关肽和内皮素在充血性心力衰竭中的作用[J].临床心血管病杂志,1998,14(3):146-147. 被引量:21
  • 10张向东,胡发国,闫雪梅,王敏,张瑞.乌拉地尔对充血性心力衰竭患者血流动力学的影响[J].临床心血管病杂志,1998,14(5):321-321. 被引量:7

共引文献21

同被引文献26

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部